Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 103, Issue 35, 2006, Pages 13068-13073

  Maussang, David ^a   Verzijl, Dennis ^a   Van Walsum, Marijke ^b   Leurs, Rob ^a   Holl, Jens ^c   Pleskoff, Olivier ^a   Michel, Detlef ^c   Van Dongen, Guus A M S ^b   Smit, Martine J ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Cancer; Drug target; G protein coupled receptor; VEGF; Viral infection

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR US28; CYCLIN D1; GUANINE NUCLEOTIDE BINDING PROTEIN; HYPOXIA INDUCIBLE FACTOR 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; STAT3 PROTEIN; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; UO 126; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE PROGRESSION; CELL GROWTH; CELL STRAIN 3T3; CELL STRAIN COS7; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GLIOBLASTOMA; HUMAN CYTOMEGALOVIRUS; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS CARCINOGENESIS; VIRUS ONCOGENE; WESTERN BLOTTING;

ANIMALS; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOMEGALOVIRUS; FEMALE; GENE EXPRESSION; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; MICE; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NIH 3T3 CELLS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHENOTYPE; PROMOTER REGIONS (GENETICS); RECEPTORS, CHEMOKINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VIRAL PROTEINS;

HERPESVIRIDAE; HUMAN HERPESVIRUS 5; MUS MUSCULUS;

EID: 33748336259     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0604433103     Document Type: Article

References (32)

1. Gandhi, M. K. & Khanna, R. (2004) Lancet Infect. Dis. 4, 725-738.
2. Stassen, F. R., Vega-Cordova, X., Vliegen, I. & Bruggeman, C. A. (2006) J. Clin. Virol 35, 349-353.
3. Harkins, L., Volk, A. L., Samanta, M., Mikolaenko, I., Britt, W. J., Bland, K. I. & Cobbs, C. S. (2002) Lancet 360, 1557-1563.
4. Cobbs, C. S., Harkins, L., Samanta, M., Gillespie, G. Y., Bharara, S., King, P. H., Nabors, L. B., Cobbs, C. G. & Britt, W. J. (2002) Cancer Res. 62, 3347-3350.
5. Cinatl, J., Jr., Vogel, J. U., Kotchetkov, R. & Wilhelm Doerr, H. (2004) FEMS Microbiol. Rev. 28, 59-77.
6. Chee, M. S., Satchwell, S. C., Preddie, E., Weston, K. M. & Barrell, B. G. (1990) Nature 344, 774-777.
7. Balkwill, F. (2004) Nat. Rev. Cancer 4, 540-550.
8. Yang, T. Y., Chen, S. C., Leach, M. W., Manfra, D., Homey, B., Wiekowski, M., Sullivan, L., Jenh, C. H., Narula, S. K., Chensue, S. W., et al (2000) J. Exp. Med. 191, 445-454.
9. Vischer, H. F., Leurs, R. & Smit, M. J. (2006) Trends Pharmacol. Sci. 27, 56-63.
10. Casarosa, P., Bakker, R. A., Verzijl, D., Navis, M., Timmerman, H., Leurs, R. & Smit, M. J. (2001) J. Biol. Chem. 276, 1133-1137.
11. Casarosa, P., Menge, W. M., Minisini, R., Otto, C., van Heteren, J., Jongejan, A., Timmerman, H., Moepps, B., Kirchhoff, F., Mertens, T., et al. (2003) J. Biol. Chem. 278, 5172-5178.
12. Streblow, D. N., Soderberg-Naucler, C., Vieira, J., Smith, P., Wakabayashi, E., Ruchti, F., Mattison, K., Altschuler, Y. & Nelson, J. A. (1999) Cell 99, 511-520.
13. Bakker, R. A., Casarosa, P., Timmerman, H., Smit, M. J. & Leurs, R. (2004) J. Biol. Chem. 279, 5152-5161.
14. Minisini, R., Tulone, C., Luske, A., Michel, D., Mertens, T., Gierschik, P. & Moepps, B. (2003) J. Virol. 77, 4489-4501.
15. Waldhoer, M., Casarosa, P., Rosenkilde, M. M., Smit, M. J., Leurs, R., Whistler, J. L. & Schwartz, T. W. (2003) J. Biol. Chem. 278, 19473-19482.
16. Sherr, C. J. (1996) Science 274, 1672-1677.
17. Radhika, V. & Dhanasekaran, N. (2001) Oncogene 20, 1607-1614.
18. Legros, L., Bourcier, C., Jacquel, A., Mahon, F. X., Cassuto, J. P., Auberger, P. & Pages, G. (2004) Blood 104, 495-501.
19. Borst, E. M., Hahn, G., Koszinowski, U. H. & Messerle, M. (1999) J. Virol, 73, 8320-8329.
20. Reinhardt, B., Schaarschmidt, P., Bessert, A., Luske, A., Finkenzeller, G., Mertens, T. & Michel, D. (2005) J. Gen. Virol. 86, 23-30.
21. Munoz, N., Bosch, F. X., de Sanjose, S., Herrero, R., Castellsague, X., Shah, K. V., Snijders, P. J. & Meijer, C. J. (2003) N. Engl. J. Med. 348, 518-527.
22. Ganem, D. (1997) Cell 91, 157-160.
23. Young, L. S. & Rickinson, A. B. (2004) Nat. Rev. Cancer 4, 757-768.
24. Pleskoff, O., Casarosa, P., Verneuil, L., Ainoun, F., Beisser, P., Smit, M., Leurs, R., Schneider, P., Michelson, S. & Ameisen, J. C. (2005) FEBS J. 272, 4163-4177.
25. Rajagopal, K., Lefkowitz, R. J. & Rockman, H. A. (2005) J. Clin. Invest. 115, 2971-2974.
26. Kotenko, S. V., Saccani, S., Izotova, L. S., Mirochnitchenko, O. V. & Pestka, S. (2000) Proc. Natl. Acad. Sci. USA 97, 1695-1700.
27. Doniger, J., Muralidhar, S. & Rosenthal, L. J. (1999) Clin. Microbiol. Rev. 12, 367-382.
28. Castillo, J. P. & Kowalik, T. F. (2002) Gene 290, 19-34.
29. Westphal, R. S. & Sanders-Bush, E. (1996) Mol. Pharmacol. 49, 474-480.
30. Finkenzeller, G., Sparacio, A., Technau, A., Marme, D. & Siemeister, G. (1997) Oncogene 15, 669-676.
31. Burger, M., Burger, J. A., Hoch, R. C., Oades, Z., Takamori, H. & Schraufstatter, I. U. (1999) J. Immunol. 163, 2017-2022.
32. Wagner, M. & Koszinowski, U. H. (2004) Methods Mol. Biol. 256, 257-268.